Holen Sie sich die Stockscreener-App
4.96
2.91%
-0.19
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SCYX?
Forum
Prognose
Aktiensplit
Scynexis Inc Aktie (SCYX) Neueste Nachrichten
SCYNEXIS Inc. (SCYX) Advances 1.92% to $5.32 as Stock Holds Above Key $5.05 SupportDiamond Pattern - vinanet.vn
Scynexis Inc (SCYX) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
SCYNEXIS, Inc. (SCYX) latest stock news and headlines - Yahoo Finance Australia
SCYNEXIS to Participate in Upcoming Investor Conferences - The Manila Times
Scynexis Inc (SCYX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
SCYNEXIS Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Press Release: SCYNEXIS Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - Moomoo
SCYNEXIS (SCYX) Market: Moves 3.60% Up to $5.33; Boundary Watch: the Near-Term Reference Band Stretches From $5.06 to $5.60 under the Current SnapshotShort Setup Alerts - vinanet.vn
SCYNEXIS (NASDAQ:SCYX) Upgraded at Wall Street Zen - MarketBeat
SCYX Q1 2026 Earnings: Deep EPS Miss and Missing Revenue Put Pipeline Execution in FocusEstimate Dispersion - vinanet.vn
SCYNEXIS (SCYX) investors CVI and Heights disclose 5.9% ownership stake - Stock Titan
Revenue per share of SCYNEXIS, Inc. – DUS:135 - TradingView
Free cash flow per share of SCYNEXIS, Inc. – DUS:135 - TradingView
SCYNEXIS, Inc. Earnings and Revenue – DUS:135 - TradingView
135 Forecast — Price Target — Prediction for 2027 - TradingView
SCYNEXIS, Inc.: Fundamental Analysis and Financial Ratings | 135 | US8112923094 - marketscreener.com
Great Point Partners (SCYX) reports 9.99% beneficial stake in Scynexis - Stock Titan
Results: SCYNEXIS, Inc. Confounded Analyst Expectations With A Surprise Profit - simplywall.st
SCYX Maintained by Guggenheim -- Price Target Raised to $33.00 - GuruFocus
Guggenheim raises Scynexis stock price target to $33 on drug potential - Investing.com Nigeria
Adage Capital group (SCYX) discloses 1,041,824-share SCYNEXIS stake including warrants - Stock Titan
Scynexis Inc earnings beat by $1.14, revenue topped estimates - Investing.com Nigeria
SCYNEXIS Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
SCYX Looks 78.3% Undervalued on GF Value™ Despite Challenging Fu - GuruFocus
Scynexis Q2 adjusted EPS misses estimate as sales decline 82.77% - scanx.trade
Scynexis: Q2 Earnings Snapshot - AOL.com
SCYNEXIS (NASDAQ:SCYX) Announces Quarterly Earnings Results, Beats Expectations By $1.14 EPS - marketbeat.com
Scynexis Q2 swings to profit on warrant adjustment; advances drug studies - TradingView
Scynexis (NASDAQ: SCYX) lifts cash and pipeline with Q2 2026 moves - Stock Titan
SCYNEXIS, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
SCYNEXIS (NASDAQ:SCYX) Lowered to Strong Sell Rating by Wall Street Zen - MarketBeat
SCYNEXIS Inc expected to post a loss of 51 cents a shareEarnings Preview - TradingView
SCYNEXIS Inc. R (135.MU) insider ownership and holdings - Yahoo Finance Australia
SCYNEXIS Inc (SCYX) Stock News Today - TradingKey
SCYNEXIS Inc (SCYX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SCYNEXIS (SCYX) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Scynexis Deadline Alert - TMX Newsfile
SCYX Q1 2026 Earnings: Wider-Than-Expected Loss of -$3.36 Per Share, Yet Stock Climbs 30.46%Segment Revenue Breakdown - vinanet.vn
Scynexis stock price target reiterated at $44.64 by Brookline - Investing.com Nigeria
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
SCYNEXIS Inc (SCYX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
SCYNEXIS Inc (SCYX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
SCYX|SCYNEXIS Inc|Price:3.560|Chg%:-0.170 - TradingKey
SCYNEXIS Inc (SCYX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SCYNEXIS Inc (SCYX) Balance Sheet - TradingKey
SCYNEXIS Inc (SCYX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
SCYNEXIS Inc (SCYX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SCYNEXIS Inc (SCYX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
SCYNEXIS (SCYX) Slips 5.8% as Biotech Stock Nears Critical Support at $3.54Insider Selling Alerts - Vinanet
SCYNEXIS, Inc. Revenue Breakdown – NASDAQ:SCYX - TradingView
SCYX Q1 2026 Earnings: Significant EPS Miss with No Revenue ReportedPeak Earnings Alert - vinanet.vn
SCYNEXIS, Inc. Revenue Breakdown – LSE:0L49 - TradingView
SCYNEXIS (SCYX) Slides 2.35% as Biotech Stock Tests Key Support LevelInsider Buying Alerts - dars.gov.et
0.33%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):